Interleukin-9 rescues class switching of Memory B cells derived from Common variable immunodeficiency patients

Clin Immunol. 2023 Sep:254:109697. doi: 10.1016/j.clim.2023.109697. Epub 2023 Jul 20.

Abstract

Impaired class switch memory (CSM) B cell formation is the hallmark of common variable immunodeficiency (CVID). Various T cell abnormalities have been observed in CVID patients indicating inadequate T-cell help to B cells. A major setback in understanding its pathogenesis is due to diverse clinical presentation. Therefore, we performed extensive immunological investigation in a cohort of CVID patients with similar clinical findings in order to unravel the T cell dysfunction and its influence on the defective humoral immune response. All recruited CVID patients exhibited B cells in the normal range, but reduced CSM B cells. However, patients showed reduced T cell proliferation, reduced level of serum Interleukin-9 (IL-9) and frequency of IL-9 expressing CD4 (Th-9) cells. IL-9 supplementation along with CD40 engagement was effective in inducing in vitro CSM B cells formation in CVID patients. Thus, IL-9 supplementation has the potential to restore impaired CSM B cell formation in CVID.

Keywords: Class switched memory B cells; Common variable immunodeficiency; Cytokines; Gastrointestinal manifestations; Humoral immune response; Interleukin-9; T helper cell.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Common Variable Immunodeficiency*
  • Humans
  • Immunoglobulin Class Switching
  • Interleukin-9*
  • Memory B Cells
  • T-Lymphocytes

Substances

  • Interleukin-9